Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

INBX

Inhibrx Biosciences (INBX)

Inhibrx Biosciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INBX
일자시간출처헤드라인심볼기업
2024/06/0105:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3107:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:34Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:34Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:32Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2905:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2507:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2505:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2505:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2505:00PR Newswire (US)Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to SanofiNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2222:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2110:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1806:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1805:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1107:36PR Newswire (US)Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-OffNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1005:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0905:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0905:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0905:37PR Newswire (US)Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated MergerNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0706:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/1205:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0906:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0905:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0706:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0604:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0508:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0107:26Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:INBXInhibrx Biosciences Inc
 검색 관련기사 보기:NASDAQ:INBX